Abbott news

As Variants Spread, Self-Reporting Can Provide Solace

BinaxNOW Self Tests allow users to self-report, helping organizations and communities monitor COVID-19.
Blog

Public health guidance, vaccination rates and rates of infection are changing quickly. But one variable remains constant when it comes to COVID: the need to quickly know if you have it or not. That's especially true as people re-enter the workplace, children go back to school, variants spread, and flu and cold season heat back up as people interact more with each other.

Strengthening Resilience in Vulnerable Communities

We're expanding our efforts to help build more resilient communities – before disaster strikes.
Blog

Today, we're faced with the stark reality that natural disasters are more frequent and more devastating than ever, leaving many — particularly those in the most vulnerable communities — in a constant state of crisis. According to the UN, climate-related disasters have increased more than 80% over the last four decades.

Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key to Unlocking Cure

Summary: 
  • Study of more than 10,000 people identifies a rare group with controlled HIV in the Democratic Republic of Congo, suggesting additional research could uncover links between natural virus suppression and future treatments
  • Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
  • Abbott's decades of work in global viral surveillance has advanced the understanding of HIV and allowed the company to quickly respond to the COVID-19 pandemic with its diagnostic tests
Press Release
  • Study of more than 10,000 people identifies a rare group with controlled HIV in the Democratic Republic of Congo, suggesting additional research could uncover links between natural virus suppression and future treatments
  • Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
  • Abbott's decades of work in global viral surveillance has advanced the understanding of HIV and allowed the company to quickly respond to the COVID-19 pandemic with its diagnostic tests
Subscribe to Abbott news